The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients by West, N P et al.
The proportion of tumour cells is an independent predictor for
survival in colorectal cancer patients
NP West
1, M Dattani
1, P McShane
2, G Hutchins
1, J Grabsch
1, W Mueller
3, D Treanor
1, P Quirke
1 and
H Grabsch*,1
1Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, University of Leeds, St James0s University Hospital, Leeds LS9 7TF, UK;
2Centre for
Epidemiology and Biostatistics, Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds LS2 9JT, UK;
3Gemeinschaftspraxis Pathologie,
Starnberg, Germany
BACKGROUND: The proportion of epithelial and stromal cells in tumours is thought to have an important role in the progression of
epithelial malignancy. We aimed to determine whether the relative proportion of tumour (PoT) was related to survival in colorectal
cancer.
METHODS: The PoT at the luminal surface was measured by point counting using virtual tissue sections in a series of 145 colorectal
cancer cases. The relationship of PoT to clinicopathological parameters including cancer-specific survival was analysed. Modified
receiver operating characteristic curves were used to determine the optimum cut off points to dichotomise the data for survival
analyses.
RESULTS: Tumours with PoT-low (p47%) were associated with significantly lower cancer-specific survival when compared to PoT-high
(hazard ratio (HR)¼2.087, 95% CI¼1.088–4.003, P¼0.024). On sub-analysis, the prognostic effect remained significant in colonic
tumours (HR¼2.474, 95% CI¼1.132–5.408, P¼0.019) and tumour, node, metastasis stage III disease (HR¼3.480, 95%
CI¼0.325–9.136, P¼0.007). Multivariate Cox regression analysis demonstrated that PoT was an independent prognostic marker
when adjusted for age, T stage, N stage and extramural vascular invasion (P¼0.017).
CONCLUSION: This study suggests that a low proportion of tumour cells in colorectal cancer is related to poor cancer-specific survival.
A relatively quick, inexpensive and well-established method such as point counting on diagnostic tissue sections could be used to
identify a subset of patients who may benefit from adjuvant therapy.
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Colorectal cancer (CRC) is a common disease and despite
significant advances in its treatment, the 5-year overall survival
remains around 50% (Cancer Research UK, 2009). Recent figures
show that CRC is now the second commonest cause of cancer
related mortality in the United Kingdom with over 16000 deaths
occurring annually (Cancer Research UK, 2009). Staging systems
such as Dukes (Gabriel et al, 1935) and tumour, node, metastasis
(TNM) (Sobin and Wittekind, 1997, pp 66–69) are routinely used to
predict prognosis following surgery, however, patients diagnosed at
the same stage of disease often have markedly different outcomes
(Morris et al, 2007). Current research aims to identify additional
prognostic markers that can be used to stratify CRC patients and
identify those which may benefit from adjuvant therapy.
Similar to all other malignant epithelial tumours, CRC is
composed of carcinoma cells admixed with stromal fibroblasts,
lymphatic and vascular channels, and inflammatory cells, often
referred to as the tumour microenvironment. This microenviron-
ment is becoming increasingly recognised as having an important
role in tumour cell invasion and the ability to metastasise
(De Wever and Mareel, 2003).
Very few studies in selected cancer subtypes, such as breast
(Baak et al, 1985), lung (Nakajima, 1991; Maeshima et al, 2002;
Das Neves Pereira et al, 2004), skin (Breuninger et al, 1997) and
prostate cancer (Yanagisawa et al, 2007) have quantified the
cellular components of primary tumours and demonstrated that
the tumour composition is associated with patient survival. In
CRC, the number of stromal myofibroblasts (Tsujino et al, 2007),
vimentin expression (Ngan et al, 2007) and degree of stromal
desmoplasia (Halvorsen and Seim, 1989; Shepherd et al, 1997;
Sis et al, 2005) have been associated with patient prognosis in
the past. So far, only one study has suggested that the proportion
of tumour cells in CRC may be important (Mesker et al,
2007). However, this result was based upon a relatively small
number of cases using qualitative visual estimation of the epithelial
component rather than measuring the components objectively
by a well-established morphometric method, such as point
counting that was first described in the 1940s (Chalkley, 1943)
and developed further by Weibel in the 1960s and 70s (Weibel,
1969).
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sWe hypothesised that the relative proportion of tumour (PoT)
determined by objective point counting on virtual (scanned)
haematoxylin and eosin-stained slides is related to cancer-specific
survival in CRC patients.
MATERIALS AND METHODS
Patients
A total of 145 patients who had potentially curative resections for
colorectal adenocarcinoma at the Marienhospital, Du ¨sseldorf,
Germany between January 1990 and December 1995 were selected
for this study. None of the patients had received pre-operative
chemotherapy or radiotherapy. The median follow-up time was
4.3 years (interquartile range¼2.2–6.2 years) and 107 patients
(73.8%) were alive at the end of the study period.
Clinicopathological data
Histopathological staging data was obtained from the pathology
reports or from slide review by one of the pathologists (WM) and
included the site of the tumour, extramural vascular invasion
status, maximum depth of invasion (pT), lymph node involvement
(pN) and distant metastasis (pM) according to TNM classification,
5th edition (Sobin and Wittekind, 1997, pp 66–69). In addition, we
had access to data regarding patient age at diagnosis and whether
or not adjuvant therapy was given.
Measurement of the relative PoT
Four mm thick haematoxylin and eosin-stained tissue sections
prepared according to standard protocols from one tumour block
representing the deepest tumour infiltration into the wall and the
largest tumour volume were scanned at  40 magnification with
an automated scanning system (Aperio XT, Aperio Technologies,
Vista, CA, USA). Using a digital slide viewer (ImageScope v8.0,
Aperio Technologies), slides were inspected after scanning and a
number of preliminary analyses were carried out on a small
number of cases to establish the optimal frequency of points and
optimal size of the area required to accurately assess the PoT (data
not shown). An area of 9mm
2 was selected from the luminal
surface of each case in which the tumour cell density seemed to be
greatest after visual inspection. A grid with a systematic random
sample of 300 points was then superimposed on the selected area
using newly developed virtual graticule software (RandomSpot,
University of Leeds, Leeds, UK) to count the number of times the
point fell over each of the categories. Large areas of necrosis and
mucus at the surface were avoided when selecting the area. The
number of necessary measurement points established in our
preliminary work was consistent with previous descriptions of
the number of points needed to accurately assess PoT (Baak et al,
1991, pp 189–209). The following categories were used in the
scoring system: tumour (the point falls onto a viable cancer cell),
stroma, tumour lumen, necrosis, vessel, inflammation and non-
informative (unclassifiable). One of the authors (MD) was trained
by an experienced pathologist (HG) in recognising the different
categories and subsequently navigated through each point and
categorised the material underneath the point while blinded to the
histopathological and survival data (Figure 1). To assess inter-
observer variation, a random sample of 40 cases were double
scored by a second pathologist (GH). As MD and GH agreed in
98.3% of the counts (k¼0.971), double scoring of all counts was
felt to be unnecessary. The PoT was expressed as a percentage
fraction of all the informative points per case. Each case took
approximately 20min to score.
Statistical analyses
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS v15.0, Chicago, IL, USA).
Comparisons between PoT and clinicopathological variables were
performed using the Mann–Whitney U or Kruskal–Wallis test as
appropriate. Correlation analyses were performed using Pearson’s
correlation coefficients.
The primary endpoint was death attributable to CRC. Cancer-
specific survival data were available for all patients. Using a
modified receiver operating characteristic curve approach devel-
oped by one of the authors (PMcS), the cut off for dichotomisation
of PoT with the highest sensitivity and specificity regarding
survival prediction was calculated (Figure 2). Using this approach,
PoT was classified as either PoT-high (447% of tumour cells
within the tumour) or PoT-low (p47% of tumour cells within the
tumour).
Patients who died within 30 days after surgery (post-operative
mortality) were excluded from the study. Univariate survival
analyses were performed using Kaplan–Meier curves (Kaplan and
Meier, 1958) and differences between the groups assessed with the
Tumour
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Figure 1 Morphometric method for establishing the PoT. (A) Selection
of a 9mm
2 area at the luminal surface of a haematoxylin and eosin-stained
representative section of colorectal cancer. A total of 300 points are
randomly inserted into the selected area. (B) Annotation of four individual
points comprised of tumour and stroma.
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Figure 2 Modified receiver operating characteristic curve used to
determine the optimal cut off point for PoT for the subsequent survival
analyses. The optimal point is determined from the peak of the curve.
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marker predicts survival independent from known prognostic
markers, such as pT, pN, extramural blood vessel invasion and
age, multivariate survival analyses were performed using the Cox
proportional hazards regression model (Cox, 1972). P-values of
less than 0.05 were considered to be statistically significant.
Ethical approval
Ethical approval for the study was granted by the Northern and
Yorkshire Research Ethics Committee, Jarrow, UK (unique
reference number 08/H0903/62).
RESULTS
Clinicopathological data
The median age of patients was 69 years (interquartile range from
61 to 76 years). The remaining clinicopathological data is
displayed in Table 1.
Relative proportion of tumour (PoT)
The PoT value followed a normal distribution across the series
ranging from 21.6 to 84.3% (see Figure 3). The median PoT value
was 57.1% (interquartile range from 47.4 to 66.4%). The relation-
ship between high and low PoT with clinicopathological data is
shown in Table 1. There was no significant correlation between
PoT and any of the clinicopathological variables, however, a low
PoT was weakly related to pT stage rising from 9% in pT1 to 42%
in pT4. The frequency of low PoT was higher in cancers of the
rectum compared with cancers of the colon, however, this was not
statistically significant (33 vs 21%, P¼0.125). The PoT value was
strongly inversely correlated with the proportion of stroma within
the tumour (r¼ 0.913, Po0.0001).
Survival analyses
The results of the survival analyses for all cases are shown in
Table 2. On univariate analysis, PoT-low was associated with
poorer cancer-specific survival (hazard ratio (HR)¼2.087, 95%
confidence interval (CI)¼1.088–4.003, P¼0.024, Figure 4). This
was also significant when follow-up was censored at 3 years
(HR¼2.878, 95% CI¼1.369–6.049, P¼0.003) and 5 years
(HR¼2.083, 95% CI¼1.066–4.072, P¼0.028). Multivariate
Table 1 Clinicopathological data and its association with the proportion
of PoT
Proportion of tumour
All cases
High Low
n % n % n% P -value
Gender
Male 58 40 44 40 14 40 1.000
Female 87 60 66 60 21 60
Tumour location
Colon 102 70 81 74 21 60 0.125
Rectum 43 30 29 26 14 40
Adjuvant treatment
Yes 21 15 93 85 31 89 0.557
No 124 86 17 15 4 11
Depth of invasion (pT)
pT1 11 8 10 9 1 3 0.064
pT2 27 19 22 20 5 14
pT3 95 66 71 65 24 69
pT4 12 8 7 6 5 14
Lymph node status (pN)
pN0 97 67 75 68 22 63 0.650
pN1 30 21 21 19 9 26
pN2 18 12 14 13 4 11
Distant metastasis (pM)
pM0 143 99 109 99 34 97 0.391
pM1 2 1 1 1 1 3
TNM stage
I 33 23 27 25 6 17 0.294
II 62 43 47 43 15 43
III 48 33 35 32 13 37
I V 21 1113
Extramural vascular invasion
No 140 97 106 96 34 97 0.826
Y e s 53 4413
Abbreviations: PoT¼proportion of tumour; TNM¼tumour, node, metastasis.
Staging data was obtained using TNM, 5th edition (Sobin and Wittekind, 1997, pp
66–69). Clinicopathological data and its association with the proportion of tumour
(PoT) which has been dichotomised into PoT-high (447% of tumour cells) and
PoT-low (p47% of tumour cells).
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Figure 3 The distribution of the proportion of tumour cells across the
colorectal cancer patient population.
Table 2 Univariate survival data obtained with the log-rank test
Univariate data
Multivariate data
Chi-square Df P-value P-value
Age (per 10-year increase) 11.824 4 0.019 0.019
Gender 1.247 1 0.264 —
Tumour location 0.061 1 0.805 —
Adjuvant treatment given 0.783 1 0.376 —
Depth of invasion (pT) 20.974 3 o0.0001 0.070
Lymph node status (pN) 6.283 2 0.043 0.011
Distant metastasis (pM) 0.336 1 0.562 —
Extramural vascular invasion 5.076 1 0.024 0.016
Proportion of tumour 5.129 1 0.024 0.017
Abbreviation: Df¼degrees of freedom. Univariate survival data obtained with the
log rank test for the various clinicopathological variables, along with the relevant
multivariate P-values obtained using a Cox proportional hazards regression analysis.
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prognostic marker when the model was adjusted for age, pT stage,
pN stage and extramural vascular invasion (P¼0.017).
Subgroup analyses by tumour location demonstrated that
PoT is a significant prognostic factor in colonic cancers
(HR¼2.474, 95% CI¼1.132–5.408, P¼0.019) but not in rectal
cancers (HR¼1.693, 95% CI¼0.516–5.562, P¼0.380). This result
was confirmed on multivariate analysis for both colonic
(HR¼2.703, 95% CI¼1.183–6.175, P¼0.018) and rectal cancers
(HR¼1.610, 95% CI¼0.471–5.505, P¼0.448). Table 3 shows
the survival analyses according to the TNM stage of disease.
The prognostic effect of PoT remained in TNM stage III disease on
both univariate (HR¼3.480, 95% CI¼1.325–9.136, P¼0.007) and
multivariate analysis (HR¼3.121, 95% CI¼1.091–8.929,
P¼0.034).
DISCUSSION
Malignant tumours such as CRC are supported by a rich network
of stroma that undergoes varying degrees of modification after
epithelial cell invasion including desmoplasia (Hewitt et al, 1993),
angiogenesis and inflammatory cell infiltration (De Wever and
Mareel, 2003). The composition of tumours varies dramatically
among patients and has previously been linked to differential
survival in the breast (Baak et al, 1985), lung (Nakajima, 1991;
Maeshima et al, 2002; das Neves Pereira et al, 2004), skin
(Breuninger et al, 1997), prostate cancer (Yanagisawa et al, 2007)
and CRC (Halvorsen and Seim, 1989; Shepherd et al, 1997;
Sis et al, 2005; Ngan et al, 2007; Tsujino et al, 2007). Most of these
studies demonstrate that a greater proportion of stroma or an
exaggerated desmoplastic response is associated with poorer
patient outcomes (Jass, 1986; Roncucci et al, 1996). Studies in
human colon cancer cell lines have shown that organ-specific
fibroblasts can directly influence the ability of the tumour cells to
invade through the production of factors such as collagenases
(Fabra et al, 1992). Molecular studies have shown that specific
chromosomal aberrations are related to the proportion of tumour
in CRC and therefore may affect tumour–stroma interactions
(Fijneman et al, 2007). Quantitative methods to evaluate desmo-
plasia including computer-assisted image analysis have already
been shown to improve reproducibility of the assessment and
have confirmed a relationship to survival (Sis et al, 2005; Tsujino
et al, 2007).
Not surprisingly, our study demonstrated that the proportion of
viable tumour cells within a tumour is strongly correlated to the
proportion of stroma. Using quantitative point counting on virtual
tissue sections, we have shown that a low proportion of malignant
epithelial cells within a given CRC is independently associated with
worse cancer-specific survival. The prognostic effect of PoT
seemed to be more significant in colonic cancers and TNM stage
III disease than rectal cancers and TNM stages I and II, although
due to the small numbers involved in these subgroup analyses the
results must be viewed with caution and need to be confirmed in a
larger series of cases.
There are several theories as to why a low PoT (and therefore
high proportion of stroma) within a tumour may infer a poor
prognosis. First, it has been hypothesised that tumours with a
greater proportion of reactive stroma are able to produce more
growth factors thus increasing the overall tumour burden
(De Wever and Mareel, 2003). Second, it has been suggested that
the relative amount of desmoplastic fibrosis may have a role in
reducing the accessibility of tumours to the immune response
(Kouniavsky et al, 2002) by encapsulating the malignant cells and
preventing their destruction (Liotta et al, 1983). However, one
must consider that PoT may reflect the stage of disease, and our
study suggests a weak correlation between PoT-low and pT stage,
which is in concordance with one previous study in which low PoT
was seen in 8% of stage I patients and in up to 69% of stage III
patients (Mesker et al, 2007).
Morphometrical analysis enables accurate quantification
of various tissue components when compared with qualitative
systems. The traditional method of using optical graticules
on conventional glass slides has limited flexibility. Using software
that can insert any number of sampling points within a
systematic grid onto a virtual slide (Treanor et al, 2008), scores
can be entered and saved as an electronic file for further analysis.
Although we have used primary resection material in this study,
analysis of stromal grade has been shown to be prognostic
on biopsy material from the prostate (Yanagisawa et al, 2007) and
our technique could potentially be used on pre-operative biopsies
of CRC.
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Figure 4 Kaplan–Meier survival curve after stratification by PoT. Hazard
ratio for PoT-low¼2.087 (95% confidence interval¼1.088–4.003).
Table 3 Univariate survival data obtained with the log rank test according to TNM stage for PoT-high vs PoT-low
Univariate data
Multivariate data
n (%) Median PoT (IQR) Chi-square Df P-value P-value
TNM stage I 33 (23) 57 (51–64) 0.116 1 0.734 0.554
TNM stage II 62 (43) 58 (50–68) 1.013 1 0.314 0.230
TNM stage III 48 (33) 55 (45–68) 7.240 1 0.007 0.034
Abbreviations: Df¼degree of freedom; IQR¼interquartile range; PoT¼proportion of tumour; TNM¼tumour, node, metastasis classification. Also shown are the multivariate
P-values obtained using a Cox proportional hazards regression analysis (adjusted for age and extramural vascular invasion). TNM stage IV is not included as only two cases fell into
this category.
The proportion of tumour in colorectal cancer
NP West et al
1522
British Journal of Cancer (2010) 102(10), 1519–1523 & 2010 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sWe and others have observed significant heterogeneity in the
PoT within individual tumours (Mesker et al, 2007). In this study,
we selected an area at the luminal surface to allow future
investigation to determine whether the results may be extrapolated
to diagnostic biopsy material. It is possible that different results
may be acquired if the measurements were performed in different
areas of the tumour, for example, the centre or the advancing edge.
In breast cancer, some studies have shown a better prognosis with
higher PoT at the tumour periphery (Baak et al, 1985), whereas
others have suggested an inverse relationship when assessing the
whole tumour (Tanaka et al, 2004).
Much of the recent research into optimising CRC patient
management has focussed on identifying (i) prognostic markers
that allow us to determine which patients may benefit from
adjuvant therapy and (ii) predictive markers which predict the
response of individual patients to specific therapeutic regimens.
The identification of patients with a poor prognosis based on an
estimate of PoT obtained through simple, relatively inexpensive
morphometrical measurements could easily be transferred into
routine diagnostic practice according to our own experience. On
the basis of the results of our present study, we hypothesise that
patients with PoT-low may be more likely to respond to agents
directed at inhibiting the crosstalk between stromal and epithelial
cells, an area that clearly warrants further investigations.
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